Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← François Rochon, latest 13F

Novo Nordisk

In François Rochon's portfolio · Giverny Capital

Ticker NVO

Not in the portfolio as of Q3 2026. Every quarter it shows up in a Giverny Capital 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q2 2026 Sell 0  
Q1 2026 No change 12,400 0.0% $36.75 $456K
Q4 2025 No change 12,400 0.0% $50.88 $631K
Q3 2025 No change 12,400 0.0% $55.49 $688K
Q2 2025 No change 12,400 0.0% $69.02 $856K
Q1 2025 No change 12,400 0.0% $69.44 $861K
Q4 2024 No change 12,400 0.0% $86.02 $1.1M
Q3 2024 No change 12,400 0.1% $119.07 $1.5M
Q2 2024 No change 12,400 0.1% $142.74 $1.8M
Q1 2024 No change 12,400 0.1% $128.40 $1.6M
Q4 2023 No change 12,400 0.1% $103.45 $1.3M
Q3 2023 Add 100% 12,400 0.1% $90.94 $1.1M
Q2 2023 No change 6,200 0.1% $161.83 $1.0M
Q1 2023 No change 6,200 0.1% $159.14 $987K
Q4 2022 No change 6,200 0.1% $135.34 $839K
Q3 2022 No change 6,200 0.0% $99.68 $618K
Q2 2022 No change 6,200 0.0% $111.45 $691K
Q1 2022 No change 6,200 0.0% $111.13 $689K
Q4 2021 Reduce 50% 6,200 0.0% $111.94 $694K
Q3 2021 Add 100% 12,400 0.0% $95.97 $1.2M
Q2 2021 No change 6,200 0.0% $83.71 $519K
Q1 2021 No change 6,200 0.0% $67.42 $418K
Q4 2020 No change 6,200 0.0% $69.84 $433K
Q3 2020 Buy 6,200 0.0% $69.35 $430K

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.